Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Jacobs syndrome 3Thrombocytopenia 2Osteosarcoma 2Neuroblastoma 2Multiple Myeloma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Testicular Neoplasms 1Sezary Syndrome 1Rhabdomyosarcoma 1Retinoblastoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Neutropenia 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Mycosis Fungoides 1Melanoma 1Medulloblastoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Thrombopoietin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cancer Treatment Induced Thrombocytopenia × Thrombopoietin × Clear all
NCT05411705 2024-03-01

Circular

The First Affiliated Hospital of Dalian Medical University

Phase 4 Unknown
165 enrolled
Classical hematology

Cancer Treatment Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡